9Osaki T. Bronchial arterial infusion is an effective therapeutic modality for centrally located early-stage lung cancer [J]. Chest, 1999,115 (8) : 1424-1426.
10Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors[J].JNCI,2000,92(3):205.
1Jagasia MH,Langer CJ,Johson DH. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer:A multicenter phaseⅡstudy[J].Clinical Cancer Research,2001,(01):68-73.
2Hirose T,Horichi N,Ohmori T. PhaseⅡstudy of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer[J].Lung Cancer,2003,(03):333-338.
3Mascaux C,Paesmans M,Berghmans T. European Lung Cancer Working Party (ELCWP).A systematic review of the role of etoposide and cisplatin in the chemotherapy of small-cell lung cancer with methodology assessment and meta-analysis[J].Lung Cancer,2000,(01):23-36.
4Sundstrom S,Bremnes RM,Kaasa S. Cisplatin and etoposide regimen is superior to cyclophosphamide,epirubicin,and vincristine regimen in small-cell lung cancer:results from a randomized phase III trial with 5 years' follow-up[J].Journal of Clinical Oncology,2002,(24):4665-4672.
5Ettinger DS,Jotte R,Lorigan P. Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer[J].Journal of Clinical Oncology,2010,(15):2598-2603.
